Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Venture to Build Cell, Gene Therapy Businesses

Gene therapy graphic

A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses

AI Analytics Find New ALS Genetic Drug Targets

Artificial intelligence graphic

Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets

Clinical Trial Set for AI-Driven Lung Fibrosis Drug

lung illustration

A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence. . . . → Read More: Clinical Trial Set for AI-Driven Lung Fibrosis Drug

Trial Shows Immunotherapy Improves Lung Cancer Survival

Inspecting lung X-rays

Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy. . . . → Read More: Trial Shows Immunotherapy Improves Lung Cancer Survival

AI Process Discovers, Tests Fibrosis Drug in 18 Months

Human lungs illustration

A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease. . . . → Read More: AI Process Discovers, Tests Fibrosis Drug in 18 Months

Large Trial Testing Covid-19 Antibody Therapies

Global Covid-19

A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies

AbbVie Acquires Coronavirus Antibody Therapy

SARS-Cov-2 virus

Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy

Infographic – Global Climate Technology Hubs

Chart: climate tech hubs

The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic. . . . → Read More: Infographic – Global Climate Technology Hubs

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Lab mouse

Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech